Moderna Inc (MRNA)
117.32
-5.37
(-4.38%)
USD |
NASDAQ |
May 10, 16:00
117.20
-0.12
(-0.10%)
After-Hours: 18:17
Moderna Cash from Investing (Quarterly): 118.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 118.00M |
December 31, 2023 | -538.00M |
September 30, 2023 | 789.00M |
June 30, 2023 | 1.944B |
March 31, 2023 | 2.011B |
December 31, 2022 | -1.048B |
September 30, 2022 | 945.00M |
June 30, 2022 | -1.152B |
March 31, 2022 | -3.921B |
December 31, 2021 | -1.138B |
September 30, 2021 | -3.327B |
June 30, 2021 | -3.878B |
March 31, 2021 | -180.00M |
Date | Value |
---|---|
December 31, 2020 | -190.00M |
September 30, 2020 | -1.179B |
June 30, 2020 | 13.00M |
March 31, 2020 | -316.00M |
December 31, 2019 | 130.29M |
September 30, 2019 | 113.37M |
June 30, 2019 | -246.90M |
March 31, 2019 | -11.76M |
December 31, 2018 | 6.173M |
September 30, 2018 | 116.08M |
June 30, 2018 | -11.64M |
March 31, 2018 | -483.70M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.921B
Minimum
Mar 2022
2.011B
Maximum
Mar 2023
-552.51M
Average
-218.45M
Median
Cash from Investing (Quarterly) Benchmarks
Merck & Co Inc | -1.376B |
Pfizer Inc | 1.732B |
Eli Lilly and Co | -1.178B |
Johnson & Johnson | -464.00M |
Novavax Inc | -9.078M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -989.00M |
Cash from Financing (Quarterly) | 14.00M |
Free Cash Flow | -3.672B |
Free Cash Flow Per Share (Quarterly) | -3.102 |
Free Cash Flow to Equity (Quarterly) | -1.185B |
Free Cash Flow to Firm (Quarterly) | -1.185B |
Free Cash Flow Yield | -8.20% |